DexCom
DXCM
#824
Rank
โ‚ฌ26.51 B
Marketcap
71,10ย โ‚ฌ
Share price
-5.98%
Change (1 day)
49.82%
Change (1 year)

P/E ratio for DexCom (DXCM)

P/E ratio as of November 2026 (TTM): 30.7

According to DexCom's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 30.6602. At the end of 2022 the company had a P/E ratio of 129.

P/E ratio history for DexCom from 2005 to 2023

PE ratio at the end of each year

Year P/E ratio Change
2022129-49.43%
2021254258.6%
202071.0-64.64%
2019201-341.22%
2018-83.2-14.47%
2017-97.327.09%
2016-76.5-31.78%
2015-112-38.86%
2014-184117.65%
2013-84.3390.1%
2012-17.225.65%
2011-13.7-0.7%
2010-13.8105.02%
2009-6.73387.32%
2008-1.38-74.68%
2007-5.45-5.47%
2006-5.7731.79%
2005-4.38

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
41.3 34.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
40.6 32.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
25.0-18.62%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
58.9 91.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
58.7 91.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-18.2-159.30%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
-0.6944-102.26%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
44.6 45.37%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.